These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11423103)

  • 1. Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological features of Alzheimer-type dementia.
    Motonaga K; Itoh M; Hirayama A; Hirano S; Becker LE; Goto Y; Takashima S
    Brain Res; 2001 Jun; 905(1-2):250-3. PubMed ID: 11423103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome.
    Busciglio J; Pelsman A; Wong C; Pigino G; Yuan M; Mori H; Yankner BA
    Neuron; 2002 Feb; 33(5):677-88. PubMed ID: 11879646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains.
    Oka A; Takashima S
    Acta Neuropathol; 1999 Mar; 97(3):275-8. PubMed ID: 10090675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the occurrence of neuronal sprouting in the frontal cortex of a patient with Down's syndrome.
    Ohara S; Tsukada M; Ikeda S
    Acta Neuropathol; 1999 Jan; 97(1):85-90. PubMed ID: 9930899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
    Helguera P; Pelsman A; Pigino G; Wolvetang E; Head E; Busciglio J
    J Neurosci; 2005 Mar; 25(9):2295-303. PubMed ID: 15745955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains.
    Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S
    Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
    Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA
    Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome.
    Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P
    Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
    Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
    Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entorhinal cortex of aged subjects with Down's syndrome shows severe neuronal loss caused by neurofibrillary pathology.
    Sadowski M; Wisniewski HM; Tarnawski M; Kozlowski PB; Lach B; Wegiel J
    Acta Neuropathol; 1999 Feb; 97(2):156-64. PubMed ID: 9928826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.
    Oka A; Takashima S
    Neuroreport; 1997 Mar; 8(5):1161-4. PubMed ID: 9175105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.
    Nunomura A; Perry G; Hirai K; Aliev G; Takeda A; Chiba S; Smith MA
    Ann N Y Acad Sci; 1999; 893():362-4. PubMed ID: 10672267
    [No Abstract]   [Full Text] [Related]  

  • 16. Developmental and aging changes in the expression patterns of beta-amyloid in the brains of normal and Down syndrome cases.
    Takashima S; Kuruta H; Mito T; Nishizawa M; Kunishita T; Tabira T
    Brain Dev; 1990; 12(4):367-71. PubMed ID: 2146899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic and histochemical development and ageing in patients with Down's syndrome.
    Takashima S; Iida K; Mito T; Arima M
    J Intellect Disabil Res; 1994 Jun; 38 ( Pt 3)():265-73. PubMed ID: 8061472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions.
    Wisniewski T; Lalowski M; Baumann M; Rauvala H; Raulo E; Nolo R; Frangione B
    Neuroreport; 1996 Jan; 7(2):667-71. PubMed ID: 8730853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
    Iyer AM; van Scheppingen J; Milenkovic I; Anink JJ; Lim D; Genazzani AA; Adle-Biassette H; Kovacs GG; Aronica E
    Curr Alzheimer Res; 2014; 11(7):694-705. PubMed ID: 25115540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells.
    Ramalho RM; Ribeiro PS; Solá S; Castro RE; Steer CJ; Rodrigues CM
    J Neurochem; 2004 Aug; 90(3):567-75. PubMed ID: 15255934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.